Ahead of print
Commentary
Published online: 2023-10-10
Commentary on Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer — Polish multicenter experience
DOI: 10.5603/ocp.97067
Abstract
Not available